Remix Therapeutics
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Contact
Jan | 3 | 2024
News
Get ready for the Roche (Remix), ft. a $30M small molecule deal
by
Annalee Armstrong
, Fierce Biotech
Read Article
Back to News
Media Contact
media@remixtx.com
Investor Contact
WILL O’CONNOR
Precision AQ
Will.OConnor@precisionaq.com